Stay updated on Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    - The site revision label was updated from v3.4.2 to v3.4.3. No study data or page content were changed.
    Difference
    0.1%
    Check dated 2026-03-11T23:40:24.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the funding-status notice and the v3.4.1 revision note; study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T13:57:29.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a government funding notice about potential delays and site operation status, and the revision badge was updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T10:11:32.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option on the page; capitalization tweaks were applied to QC-related labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'). The revision was bumped from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T05:49:04.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 from the page's changelog.
    Difference
    0.1%
    Check dated 2026-01-14T03:23:41.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations section added listing Arizona, California, New York, Ohio, Pennsylvania, and Texas sites. The page also shows a revision note indicating v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T22:07:56.000Z thumbnail image

Stay in the know with updates to Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.